ライフサイエンスコーパス: arteriosus

1 omethacin to treat symptomatic patent ductus arteriosus.

2 ups, as was acute constriction of the ductus arteriosus.

3 ease, there is delayed closure of the ductus arteriosus.

4 pite success in closure of the patent ductus arteriosus.

5 ar pulmonary veins or a silent patent ductus arteriosus.

6 N) following prenatal ligation of the ductus arteriosus.

7 (PPHN) after prenatal ligation of the ductus arteriosus.

8 ggesting little effect on tone of the ductus arteriosus.

9 s without clinically suspected patent ductus arteriosus.

10 l heart defects including persistent truncus arteriosus.

11 tive value for the presence of patent ductus arteriosus.

12 us, with a 92% specificity for patent ductus arteriosus.

13 H) caused by prolonged closure of the ductus arteriosus.

14 chniques for coil occlusion of patent ductus arteriosus.

15 SM2 is precociously expressed in the ductus arteriosus.

16 serve a strong beta-gal signal in the ductus arteriosus.

17 ium channels, and constriction of the ductus arteriosus.

18 to the unique muscle phenotype of the ductus arteriosus.

19 ng following coil occlusion of patent ductus arteriosus.

20 bronchopulmonary dysplasia and patent ductus arteriosus.

21 of 14 preterm infants without patent ductus arteriosus.

22 sional image of the great vessels and ductus arteriosus.

23 ticopulmonary window, and persistent truncus arteriosus.

24 ey may cause premature closure of the ductus arteriosus.

25 t ingress, with resultant persistent truncus arteriosus.

26 crotizing enterocolitis or persistent ductus arteriosus.

27 h ligand, die postnatally from patent ductus arteriosus.

28 , pulmonary stenosis, and persistent truncus arteriosus.

29 e inactivation results in persistent truncus arteriosus.

30 ar disease, tetralogy of Fallot, and truncus arteriosus.

31 velopment of smooth muscle within the ductus arteriosus.

32 terrupted aortic arch and persistent truncus arteriosus.

33 l septal defects (20/47, 43%), patent ductus arteriosus (16/47, 34%), persistent left superior vena c

34 ); superior vena cava, 137 (77, 197); ductus arteriosus, 187 (109, 265); descending aorta, 252 (160,

35 atrial septal defects, 2 with patent ductus arteriosus, 2 with tetralogy of Fallot, and 1 with pulmo

36 ition of the great vessels, 3 patient ductus arteriosus, 3 partial anomalous pulmonary venous return,

37 The narrowest diameter of the ductus arteriosus (4.3 +/- 0.4 mm vs. 6.9 +/- 2.6 mm, p > 0.1)

38 53); superior vena cava, 29 (15, 43); ductus arteriosus, 41 (25, 57); descending aorta, 55 (35, 75);

39 sia or stenosis (7 patients, 11.5%), truncus arteriosus (6 patients, 10%), TGA (10 patients, 17%), an

40 l heart disease that results when the ductus arteriosus, a muscular artery, fails to remodel and clos

41 3 knockout mice an attenuation of the ductus arteriosus, a phenotype which may be indicative of outfl

42 ly increased incidence of persistent truncus arteriosus, a phenotypic change characteristic of DGS, b

43 die at mid-gestation with persistent truncus arteriosus, a severe cardiac outflow tract defect also s

44 ivo, we show that extirpation of the bulbous arteriosus-a distinct, smooth-muscle-rich tissue structu

45 ays a critical role in closure of the ductus arteriosus after birth by ensuring a reduction in local

46 ctus arteriosus and in closure of the ductus arteriosus after birth.

47 .2+/-4.9); group B, 14 patients with truncus arteriosus, aged 27 to 50 years (mean 33.7+/-7.3), follo

48 The embryos displayed persistent truncus arteriosus and abnormalities of the great vessels.

49 patterning and differentiation of the ductus arteriosus and adjacent descending aorta.

50 entiation in the vascular wall of the ductus arteriosus and adjacent descending aorta.

51 tal defects), aortic sac (persistent truncus arteriosus and aorticopulmonary window), and aortic arch

52 In other areas, such as patent ductus arteriosus and atrioventricular septal defect, the findi

53 with catheterization stenting of the ductus arteriosus and balloon atrial septostomy, especially in

54 ionship exists between patency of the ductus arteriosus and chronic lung disease and other morbiditie

55 psy and other signs, including patent ductus arteriosus and coagulopathy, while hemizygous males die

56 Patent ductus arteriosus and coarctation of aorta occurred >3 times as

57 All patients had persistent ductus arteriosus and congenital mydriasis, and variable presen

58 A third mutation causing persistent truncus arteriosus and craniofacial defects, phenotypes reminisc

59 e inflow and direction of flow in the ductus arteriosus and descending aorta were unrelated to outcom

60 tracardiac nerve trunk innervated the bulbus arteriosus and entered the arterial pole of the heart to

61 crest ablation results in persistent truncus arteriosus and failure of addition of myocardium from th

62 lG) was identified in familial patent ductus arteriosus and found to disrupt normal splicing of MYH11

63 the embryonic defects of persistent truncus arteriosus and impaired semilunar valve formation in hum

64 h in maintaining patency of the fetal ductus arteriosus and in closure of the ductus arteriosus after

65 ease, including tetralogy of Fallot, truncus arteriosus and interruption of the aortic arch.

66 to close after birth is termed patent ductus arteriosus and is one of the most common congenital hear

67 cle differentiation in the developing ductus arteriosus and may promote precocious expression of the

68 nterest because it also causes patent ductus arteriosus and moyamoya disease.

69 e-outlet right ventricle, persistent truncus arteriosus and right-sided aortic arches.

70 ibing an association between a patent ductus arteriosus and the development of morbidities, such as c

71 trant phenotypes included persistent truncus arteriosus and thickened valve leaflets.

72 scular defects, including persistent truncus arteriosus, and abnormal maturation of the aortic arch r

73 transverse and descending aorta, the ductus arteriosus, and across the aortic and mitral valves in i

74 cardiovascular malformation, one had truncus arteriosus, and another had a bicuspid aortic valve.

75 t cardiac lesion, for example, patent ductus arteriosus, and aortic cross-clamp time were determinant

76 th interatrial communications, patent ductus arteriosus, and pulmonary artery stenosis requiring sten

77 ending aorta, paracoarctation aorta, truncus arteriosus, and pulmonary trunk in 86 patients were supp

78 ending aorta, paracoarctation aorta, truncus arteriosus, and pulmonary trunk were prevalent in patien

79 at angioplasty, presence of a patent ductus arteriosus, and the diameters of the aortic isthmus, dis

80 ehog (Hh) ligand is expressed in the bulbous arteriosus, and treatment with a Hh signalling antagonis

81 , 0.81; 95% CI, 0.67-0.98) and patent ductus arteriosus (AOR, 0.74; 95% CI, 0.62-0.89).

82 Rs ranging from 1.29 to 2.17), patent ductus arteriosus [aORs = 1.54, 1.63; 95% confidence intervals

83 ion, atrioventricular septal defect, truncus arteriosus, aortopulmonary septal defect, and totally an

84 Therapies designed to close the ductus arteriosus are contraindicated in some settings and shou

85 ch of the normoxic contraction of the ductus arteriosus at birth is related to calcium entry through

86 Closure of the ductus arteriosus at birth, essential for postnatal adaptation,

87 26+/-3 d; 147 d, term) we ligated the ductus arteriosus at surgery, and treated animals with either B

88 g stenting or stent redilation of the ductus arteriosus, balloon aortic valvuloplasty, and stenting o

89 subsequently diagnosed to have patent ductus arteriosus, based on clinical suspicion and echocardiogr

90 nts with than in those without patent ductus arteriosus because afterload is lower in the former grou

91 rioventricular septal defects, patent ductus arteriosus, bicuspid aortic valve, and coarctation of th

92 P62R, had a high prevalence of patent ductus arteriosus but had only mild abnormalities of facial fea

93 se beta-gal staining localizes to the ductus arteriosus but is absent or minimal in the pulmonary tru

94 mon after coil embolization of patent ductus arteriosus, but most close spontaneously.

95 establish and maintain patency of the ductus arteriosus by a new method of transvascular formalin inf

96 this pathway may contribute to patent ductus arteriosus by affecting the development of smooth muscle

97 y, experimental repositioning of the bulbous arteriosus by tissue recombination initiates epicardial

98 t role in control of major vessel and ductus arteriosus caliber in the rat fetus.

99 hology, osteochondrodysplasia, patent ductus arteriosus, cardiomegaly, pericardial effusion, and lymp

100 In the vast majority of infants, the ductus arteriosus closes by 3 days of life.

101 on of PGHS1-PGHS2 may explain how the ductus arteriosus closes normally at birth in mice expressing P

102 Incidence of spontaneous ductus arteriosus closure was increased, likely contributing to

103 To determine the role of PGT in ductus arteriosus closure, we used a gene-targeting strategy to

104 acolepis fossils display hearts with a conus arteriosus containing at least five valve rows.

105 ral crest-derived SMCs populating the ductus arteriosus (DA) and great arteries exhibited a cell auto

106 How the ductus arteriosus (DA) closes at birth remains unclear.

107 Wild-type embryonic ductus arteriosus (DA) exhibited high levels of PRDM6, which ra

108 The ductus arteriosus (DA) is a vessel whose patency is required fo

109 Closure of the ductus arteriosus (DA) is essential for the transition from fet

110 The ductus arteriosus (DA) of newborn infants exposed in utero to i

111 he fetus, PGs maintain patency of the ductus arteriosus (DA), a vascular shunt that transmits oxygena

112 is the closure and remodeling of the ductus arteriosus (DA), an arterial connection in the fetus tha

113 nge that occurs is the closure of the ductus arteriosus (DA), an arterial connection in the fetus tha

114 tal mammals depends on closure of the ductus arteriosus (DA), an arterial connection in the fetus whi

115 ate, including adverse effects on the ductus arteriosus (DA).

116 Fetal aortic and pulmonary valve; ductus arteriosus (DA); and right (RPA), left (LPA), and distal

117 to the genetic programs that underlie ductus arteriosus development and closure.

118 y diameter Z score <or=-2.5 or patent ductus arteriosus diameter <or=2 mm was 97% sensitive and 100%

119 ) with a secundum ASD, one each with truncus arteriosus, double-outlet right ventricle, L-transpositi

120 infant required ligation of a patent ductus arteriosus during ECMO.

121 ogenetic development of the aorta and ductus arteriosus during embryonic and postnatal survival.

122 cle layers of the tunica media in the ductus arteriosus exhibit positive beta-gal staining.

123 ominant trait characterized by patent ductus arteriosus, facial dysmorphism and hand anomalies.

124 as observed between PM(10) and patent ductus arteriosus (for an interquartile range increase in PM(10

125 inct AV valve, atrium, ventricle, and bulbus arteriosus form, accompanied by incremental increases in

126 clearance was decreased in the patent ductus arteriosus group vs. the control group (40.02 vs. 44.73

127 The infants with patent ductus arteriosus had higher values for ventricular performance

128 ranscatheter coil occlusion of patent ductus arteriosus has gained popularity, few follow-up data hav

129 revention and treatment of the patent ductus arteriosus have not documented a decrease in the inciden

130 mental defects, including persistent truncus arteriosus, hypomorphic pulmonary arteries, interrupted

131 flow tract dominated by a multi-valved conus arteriosus in basal actinopterygians, to an outflow trac

132 commanded by the non-valved, elastic, bulbus arteriosus in higher actinopterygians.

133 ription factor associated with patent ductus arteriosus in humans, was uniquely expressed in mouse du

134 rlying O2-induced constriction of the ductus arteriosus in late-gestation fetal rabbits.

135 gic flow across the atrial septum and ductus arteriosus in the human fetus.

136 remodeling, resulting in persistent truncus arteriosus in the majority of mutant embryos.

137 Ligation of the ductus arteriosus in utero produces pulmonary hypertension and

138 tor antagonist, after ligation of the ductus arteriosus in utero.

139 iopulmonary defects, including patent ductus arteriosus, in 30 to 40% of the mice.

140 ector mechanism for O2 sensing in the ductus arteriosus involves the coordinated action of delayed re

141 The ductus arteriosus is a specialized blood vessel containing high

142 The ductus arteriosus is a vessel that connects the pulmonary arter

143 The ductus arteriosus is a vital fetal structure allowing blood eje

144 The ductus arteriosus is an arterial vessel that shunts blood flow

145 and persists in the neonate until the ductus arteriosus is completely closed.

146 In the preterm newborn, a patent ductus arteriosus is in large part a result of the increased se

147 ether to perturb the rotation of the truncus arteriosus, leading to OFT malalignment defects includin

148 onary artery pressure (PAP) 8 d after ductus arteriosus ligation (78+/-2, HTN vs. 70+/-4 mmHg, BQ 123

149 Patent ductus arteriosus ligation among preterm neonates younger than

150 Since the first patent ductus arteriosus ligation by Robert Gross of Boston in 1938, a

151 4 premature infants undergoing patent ductus arteriosus ligation in a 1-year period at our institutio

152 sulted in fully penetrant persistent truncus arteriosus malformations.

153 In preterm infants, patency of the ductus arteriosus may represent a normal physiologic adaptation

154 associated with ligation of a patent ductus arteriosus might worsen ventricular performance in the p

155 reat arteries (n=14), and persistent truncus arteriosus (n=3).

156 gentamicin were administered (patent ductus arteriosus, n = 106; control, n = 216).

157 Patent ductus arteriosus occlusion can be accomplished by umbrella dep

158 ntricular septal defect, Fallot, and truncus arteriosus operations were 1.1%, 0.6%, 3.6%, 2.3%, and 2

159 f the physiologic shunting across the ductus arteriosus or atrial septum in utero (i.e., left to righ

160 Patients with persistent ductus arteriosus or congenital mydriasis with a label of 'moya

161 Impaired development of the ductus arteriosus or disruption of signaling pathways that init

162 a common arterial trunk ('persistent truncus arteriosus' or PTA).

163 secundum atrial septal defect, patent ductus arteriosus, or pulmonic stenosis have had infective endo

164 f distribution was greater for patent ductus arteriosus patients (0.61 L/kg) than for controls (0.54

165 toned device (BD) occlusion of patent ductus arteriosus (PDA) in a large number of patients with part

166 the screening and treatment of patent ductus arteriosus (PDA) in extremely preterm infants.

167 Nonsyndromic patent ductus arteriosus (PDA) is a common congenital heart defect (CH

168 Patent ductus arteriosus (PDA) is a common congenital heart disease th

169 Patent ductus arteriosus (PDA) is a relatively common form of congenit

170 Patent ductus arteriosus (PDA) is associated with increased mortality

171 tional studies have associated patent ductus arteriosus (PDA) ligation among preterm infants with adv

172 Patent ductus arteriosus (PDA) poses a diagnostic and therapeutic dile

173 to determine the frequency of patent ductus arteriosus (PDA) reopening and the factors that may pred

174 dergo palliation with either a patent ductus arteriosus (PDA) stent or a modified Blalock-Taussig (BT

175 closure of a moderate to large patent ductus arteriosus (PDA) using conventional techniques is challe

176 The patent ductus arteriosus (PDA) was the first congenital heart lesion t

177 al septal defect (ASD) and two patent ductus arteriosus (PDA) were missed by DSCT.

178 We found that patent ductus arteriosus (PDA), a common congenital heart disease, acc

179 ude the moderate to large size patent ductus arteriosus (PDA).

180 g indomethacin (INDO) to close patent ductus arteriosus (PDA).

181 ctation of the aorta (CoA) and patent ductus arteriosus (PDA).

182 al dilatation of the aorta and patent ductus arteriosus (PDA).

183 prior to postnatal day 3 from patent ductus arteriosus (PDA).

184 t 16p for TAAD associated with patent ductus arteriosus (PDA).

185 efect (ASD); device closure of patent ductus arteriosus (PDA); pulmonary valvuloplasty; aortic valvul

186 Gianturco coils to close large patent ductus arteriosus (PDAs) (> or = 3.5 mm) and describes transven

187 Maintaining patency of the ductus arteriosus postnatally is necessary with many forms of c

188 diac anomalies present as persistent truncus arteriosus (PTA) and interrupted aortic arch (IAA), whic

189 iovascular malformations--persistent truncus arteriosus (PTA) and interrupted aortic arch (IAA-B).

190 Persistent truncus arteriosus (PTA) is a failure of septation of the cardia

191 development and leads to persistent truncus arteriosus (PTA), indicative of neural crest dysfunction

192 acking Smad4 in NCCs have persistent truncus arteriosus (PTA), severe OFT cushion hypoplasia, defecti

193 such as cleft palate and persistent truncus arteriosus (PTA).

194 rioventricular septal defects; patent ductus arteriosus; pulmonary stenosis; aortic stenosis; coarcta

195 and left pulmonary arteries (QP), and ductus arteriosus (QDA) were calculated in 63 normal fetuses.

196 entricular septal defect, persistent truncus arteriosus, reduced myocardial proliferation, and embryo

197 ulates epicardial regeneration after bulbous arteriosus removal, indicating that Hh signalling can su

198 malacia, chronic lung disease, patent ductus arteriosus requiring surgery, retinopathy of prematurity

199 Although a persistent patent ductus arteriosus results in diminished cardiac function and in

200 controversy as to whether or when the ductus arteriosus should be closed by either pharmacologic or s

201 were delivered alive from the reverse ductus arteriosus shunt group and 4 of 12 from the reverse atri

202 Reversed ductus arteriosus shunting was found with severe right heart ob

203 development, a specialized vessel the ductus arteriosus, shunts blood from the pulmonary artery to th

204 defects, patent foramen ovale, patent ductus arteriosus, stent placement for pulmonary artery stenosi

205 c arch (IAA), 34.5% of patients with truncus arteriosus (TA), and 15.9% with tetralogy of Fallot (TOF

206 ion of the great arteries (TGA), and truncus arteriosus (TA).

207 n result in persistent patency of the ductus arteriosus, the third most common congenital heart defec

208 ate (DAF-2DA) specifically labels the bulbus arteriosus throughout development from approximately 48

209 e in oxygen causes contraction of the ductus arteriosus, thus diverting blood flow to the lungs.

210 Failure of the ductus arteriosus to close after birth is termed patent ductus

211 ld be altered in neonates with patent ductus arteriosus to reflect the impact of higher volume of dis

212 was defined as tetralogy of Fallot, truncus arteriosus, transposition complexes, endocardial cushion

213 notype known in humans as persistent truncus arteriosus (type A4).

214 ased, in part, on the report that the bulbus arteriosus undergoes a striated-to-smooth muscle phenoty

215 poplastic left heart syndrome, patent ductus arteriosus, valvar pulmonary stenosis, tetralogy of Fall

216 vascular formalin infiltration of the ductus arteriosus wall has been applied successfully to maintai

217 The ductus arteriosus wall was successfully infiltrated and dilated

218 vascular formalin infiltration of the ductus arteriosus wall.

219 regardless of whether preterm patent ductus arteriosus was included.

220 required surgical closure of a patent ductus arteriosus was lower in the budesonide group than in the

221 constriction of the great vessels and ductus arteriosus was observed with L-NIL, whereas both LPS and

222 A functionally closed ductus arteriosus was traversed with a specially designed porou

223 smoking in the household, and patent ductus arteriosus were predictive of wheezing in the previous 1

224 t left superior vena cava, and patent ductus arteriosus, were present in 32% of patients.

225 of better therapy to close the patent ductus arteriosus, which constitutes approximately 10% of all c

226 L605P was associated with persistent truncus arteriosus with interrupted aortic arch, and the Gja1W45

227 Necropsy revealed patent ductus arteriosus with normal intimal thickening but dilated ca

228 useful marker for presence of patent ductus arteriosus, with a 92% specificity for patent ductus art